---
created: 2025-04-13
updated: 2025-04-13T10:53
id: jTWvP/t[,]
specialty: pulmo
specialty_id: 153
tags:
  - source/ak-original-decks::step-1::zanki-step-decks::zanki-respiratory::respiratory-pathology
  - "source/ak-step1-v11:": 
  - theme/firstaid::16-respiratory::04-pathology::24-lung-cancer
  - "source/ak-step1-v11:": 
  - theme/firstaid::16-respiratory::04-pathology::24-lung-cancer::non-small-cell-carcinoma::adenocarcinoma
  - "source/ak-step1-v11:": 
  - source/ome-banner::clinical::02-pulmonology::02-lung-cancer
  - "source/ak-step1-v11:": 
  - theme/pathoma::09-respiratory::08-lung-cancer
  - "source/ak-step1-v11:": 
  - theme/physeo::11-pathology::03-pulmonary-pathology::20-lung-cancer
  - "source/ak-step1-v11:": 
  - theme/uworld::1000-9999::8000-8999::8281
  - source/ak-step1-v11::^other::^expn::bgadd
  - source/ak-step1-v11::^other::^expn::uworld
  - source/ak-step1-v11::^other::^highyield::4-loweryield
  - source/ak-step1-v11::^systems::respiratory::bgadds"
type: flashcard
---

# Question
Patients with lung cancers with a EML4-ALK fusion protein are typically seen in young **non-smokers::smoking status**  * Bonus: this molecular pathophysiology is most similar to which disorder?

---

# Answer
4% of NSCLC patients harbor a chromosomal rearrangement, creating a fusion gene between EML4 (echinoderm microtubule-associated protein-like 4) and ALK (anaplastic lymphoma kinase).   This results in a constitutive active tyrosine kinase that causes malignancy.